Synageva BioPharma (GEVA) Announces Data Presentations At The 10th Annual Lysosomal Disease Network (LDN) World Symposium
1/29/2014 7:52:58 AM
Synageva BioPharma Corp. (Synageva) (NASDAQ:GEVA), a biopharmaceutical company developing therapeutic products for rare diseases, today announced data presentations at the upcoming LDN WORLD Symposium being held February 11-13 in San Diego, California, including three oral presentations and three posters describing sebelipase alfa, lysosomal acid lipase deficiency (LAL Deficiency), and SBC-103 for MPS IIIB.
Help employers find you! Check out all the jobs and post your resume.
comments powered by